AI assistant
Sending…
Tectonic Therapeutic, Inc. — Director's Dealing 2020
Oct 21, 2020
33251_dirs_2020-10-21_6c93831e-6789-40b5-99bd-b2b3cad61d96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2020-10-19
Reporting Person: Farfel Gail M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-10-19 | Stock Option (Right to Buy) | $16.14 | A | 28000 | Acquired | 2030-10-18 | Common Stock (28000) | Direct |
Footnotes
F1: The Stock Option shall vest and become exercisable in 36 equal monthly installments over a three-year period.
More from Tectonic Therapeutic, Inc.
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10